Keyt Bruce has filed 14 insider transactions across 1 company since March 2024.
Most recent transaction: a sale of 1487 shares of IGM Biosciences, Inc. ($IGMS) on September 13, 2024.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 13, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1487 | $11.54 | 246,987.0000 | 60,434,161 | 0.60% | 0.00% |
| July 19, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 43888 | $0.00 | 245,696.0000 | 60,434,161 | 21.75% | 0.07% |
| July 19, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 2778 | $0.00 | 248,474.0000 | 60,434,161 | 1.13% | 0.00% |
| July 19, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 75000 | $0.00 | 0.0000 | 60,434,161 | 100.00% | 0.12% |
| July 19, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | D | Stock Option (right to buy) | 50000 | $0.00 | 0.0000 | 60,434,161 | 100.00% | 0.08% |
| May 15, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 3000 | $5.02 | 202,914.0000 | 52,311,958 | 1.50% | 0.01% |
| June 14, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1106 | $7.58 | 201,808.0000 | 52,311,958 | 0.55% | 0.00% |
| March 26, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 24019 | $0.00 | 199,914.0000 | 52,311,958 | 13.66% | 0.05% |
| March 13, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 2101 | $9.88 | 177,739.0000 | 52,311,958 | 1.17% | 0.00% |
| March 14, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 1844 | $10.17 | 175,895.0000 | 52,311,958 | 1.04% | 0.00% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 46250 | $0.00 | 179,840.0000 | 52,311,958 | 34.62% | 0.09% |
| March 12, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | A | Stock Option (right to buy) | 92500 | $0.00 | 92,500.0000 | 52,311,958 | 9999.99% | 0.18% |
| March 1, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 3026 | $0.93 | 133,590.0000 | 52,311,958 | 2.32% | 0.01% |
| March 1, 2024 | IGM Biosciences, Inc. | $IGMS | Keyt Bruce | CHIEF SCIENTIFIC OFFICER | M | Stock Option (right to buy) | 3026 | $0.00 | 0.0000 | 52,311,958 | 100.00% | 0.01% |